By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Purdue Pharmaceuticals L.P. 

4701 Purdue Drive

Wilson  North Carolina  27893  U.S.A.
Phone: 252-265-1900 Fax: 252-243-2533


Purdue Pharmaceuticals L.P. is a 200,000-square-foot, state-of-the-art pharmaceutical manufacturing, packaging, and distribution facility that produces oral solid dosage tablets and also distributes oral liquids and sterile injectibles for Purdue Pharma L.P., an independent associated company headquartered in Stamford, CT. These privately held companies, founded by physicians and focused on meeting the needs of healthcare providers and the patients in their care, are dedicated to finding, developing, and bringing to market new medicines and related products that improve health outcomes. The companies have long been known for their pioneering research on persistent pain, a principal cause of human suffering.

Purdue Pharma also has a growing line of non-prescription products including laxatives, microbicides, and nutraceuticals. The company is dedicated to serving the evolving needs of healthcare providers, patients, and caregivers with prescription and non-prescription medicines. A commitment to innovation and caring spans every aspect of the organization, from discovering and launching new medicines to demonstrating their medical value.

Purdue Pharma has led the battle against inadequate treatment of pain by developing sustained-release medications to manage pain. Its sales, marketing, and medical education professionals provide the healthcare community with comprehensive educational materials and programs relating to pain management.

In 1993, Purdue Pharma established Partners Against Pain® as a resource to help patients, caregivers, and healthcare professionals advance standards of pain care and alleviate unnecessary suffering through education and advocacy. Purdue has also assumed a leading role in addressing the serious public health problem of prescription drug abuse, supporting programs intended to help stem abuse.

Key Statistics

Ownership: Private

Web Site: Purdue Pharma L.P.
Employees: 195


Company News
Egalet Settles Patent Litigations With Purdue Pharma L.P. 5/23/2016 6:33:56 AM
Mundipharma And Purdue Pharma L.P. Reach A New Deal To In-Licence From ESTEVE Full Global Rights And Development Responsibilities For Novel First-In-Class Sigma-1 Antagonist (S1A Or MR309/E-52862) 5/16/2016 11:12:16 AM
Mundipharma And Purdue Pharma L.P. Expand Pain Pipeline With New Deal For First-In-Class Sigma-1 Antagonist (S1A Or MR309/E-52862) From ESTEVE 5/16/2016 7:01:48 AM
Purdue Pharma L.P. Announces The Appointment Of Alan W. Dunton, M.D. To Senior Vice President Of Research & Development 11/19/2015 6:44:06 AM
FDA Panel Votes 23 to 1 Against Purdue Pharma L.P.’s New OxyContin Formulation 9/11/2015 5:57:00 AM
Purdue Pharma L.P. Buys TrkA Program from VM Pharma LLC in $213 Million Deal 9/8/2015 6:37:18 AM
Purdue Pharma L.P. Names Gail Cawkwell, MD, PhD, Vice President Of Medical Affairs 11/17/2014 12:03:56 PM
Purdue Pharma L.P. Commercially Launches Recently Approved 7.5 Mcg/Hour Dosage Strength Of Butrans® (Buprenorphine) Transdermal System CIII 10/9/2014 7:55:44 AM
Purdue Pharma L.P. Names Susie Robinson Vice President of Human Resources 9/15/2014 9:29:01 AM
FDA To Expedite Review Of Purdue Pharma L.P. Once-Daily Painkiller Tablet 7/8/2014 8:42:42 AM